Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2012
11/14/2012CN102776155A Chinese isolated strain of bovine enterovirus, and construction and application of infectious cDNA clone thereof
11/14/2012CN102775469A Antigen epitope of influenza A virus nucleocapsid protein, and its use
11/14/2012CN102260649B Infectious bursal disease virus (IBDV) and method for preparing inactivated vaccines and combined vaccines by breeding IBDV with chick-embryo cell system and bioreactor
11/14/2012CN102154356B Hybrid immunodeficiency plasmid containing human immunodeficiency virus (HIV)-1 circulating recombinant form (CRF) 01-AE subtype reverse transcriptase (RT) gene, virus and use
11/14/2012CN102127524B Method for proliferating avian influenza viruses in bioreactor with cell carrier
11/14/2012CN101164623B Methods for concentrating virus preparations
11/13/2012US8309326 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
11/13/2012US8309099 DNA transfection system for the generation of negative strand RNA virus
11/13/2012CA2518546C Improved alphavirus replicons and helper constructs
11/13/2012CA2397675C Altered strain of the modified vaccinia virus ankara (mva)
11/08/2012WO2012150478A1 Adenovirus vaccine vectors
11/08/2012WO2011151470A3 Methods and helper viruses for the generation of rna virus
11/08/2012US20120282674 Method for the preparation of an influenza virus
11/08/2012US20120282673 Functional mutation in respiratory syncytial virus
11/08/2012US20120282239 Novel mannanase variants
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/07/2012EP2520310A1 Cellular permissivity factor for viruses, and uses thereof
11/07/2012EP2519627A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages
11/07/2012EP2519539A2 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
11/07/2012EP2519266A2 Infectious dna vaccines against chikungunya virus
11/07/2012CN1524088B A virus causing respiratory tract illness in susceptible mammals
11/07/2012CN102770527A Lactic bacterium for texturizing food products selected on basis of phage resistance
11/07/2012CN102770146A Simian adenovirus and methods of use
11/07/2012CN102766606A Method for replicating influenza virus in culture
11/07/2012CN102766605A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
11/07/2012CN102766604A Swine influenza virus strain and application thereof
11/07/2012CN102766603A Chicken Newcastle disease virus and its separation method
11/07/2012CN102766207A Bactrian camel heavy-chain (HC) variable-domain antibody resisting porcine circovirus 2 as well as preparation method and application thereof
11/07/2012CN102764432A Chinese giant salamander viral hemorrhagic disease cell culture-based inactivated vaccine, its preparation method and application thereof
11/07/2012CN102041247B Salmonella bacteriophage and application thereof
11/07/2012CN101748123B Manufacturing method of adjustable liver damage animal model and special DNA fragment thereof
11/07/2012CN101194012B Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
11/06/2012CA2494379C Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/06/2012CA2326724C Mixed cell diagnostic systems
11/01/2012WO2012149439A2 Il4/il13 binding repeat proteins and uses
11/01/2012WO2012148708A1 Modified sendai virus vaccine and imaging vector
11/01/2012WO2012147928A1 Agent for preventing bacterial wilt disease, and method for preventing bacterial wilt disease
11/01/2012WO2012146630A1 N-terminal acylated polypeptides, methods for their production and uses thereof
11/01/2012WO2012145837A1 Methods of purifying viruses using gel permeation chromatography
11/01/2012WO2012106403A3 Methods and compositions for pseudoinfectious alphaviruses
11/01/2012WO2012036580A3 Antibacterial phage, phage peptides and methods of use thereof
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120276614 Process for producing poxviruses and poxvirus compositions
11/01/2012US20120276613 Modified vaccinia ankara virus variant and cultivation method
11/01/2012US20120276612 Phage of acinetobacter baumannii
11/01/2012US20120276078 Glycosidase enzymes
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120276010 Microorganisms for therapy
11/01/2012US20120275999 Oncolytic rhabdovirus
11/01/2012US20120273424 Methods of purifying viruses using gel permeation chromatography
11/01/2012CA2834624A1 Il4/il13 binding repeat proteins and uses
11/01/2012CA2832367A1 Methods of purifying viruses using gel permeation chromatography
10/2012
10/31/2012EP2516649A2 Novel pneumovirus compositions and methods for using the same
10/31/2012EP2516629A2 Herpes simplex virus vaccines
10/31/2012CN102762721A Method for the production of Ad26 adenoviral vectors
10/31/2012CN102757942A Recombinant vaccine strain for foot-and-mouth disease type A as well as preparation method thereof and application thereof
10/31/2012CN102757941A Hepatitis A virus strain HAV-ZL2012, vaccine prepared by using same and application thereof
10/31/2012CN102757940A Duck flavivirus and preparation and application of inactivated vaccine of duck flavivirus
10/31/2012CN102757502A Fused human interleukin 28B and preparation method thereof
10/31/2012CN102755644A Rabbit haemorrhagic disease tissue inactivated vaccine and preparation method thereof
10/31/2012CN101474552B Media for membrane ion exchange chromatography
10/30/2012US8299215 Methods and compositions for treating brain diseases
10/30/2012US8299031 Human semen enhancer of viral infection peptides (SEVI) and their use
10/30/2012US8298826 Chimaeric vector system
10/30/2012US8298805 Signal for packaging of influenza virus vectors
10/30/2012US8298541 Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
10/26/2012WO2012145624A2 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
10/26/2012WO2012145597A2 Recombinant virus products and methods for inhibition of expression of myotilin
10/26/2012WO2012145386A1 Methods for isolating and quantifying antigen from vaccines
10/26/2012WO2012145375A1 Method to produce virus in cultured cells
10/26/2012WO2012144446A1 Drug delivery particles and method for producing same
10/26/2012WO2011138040A3 Vaccine against beta-herpesvirus infection and use thereof
10/26/2012CA2839773A1 Recombinant virus products and methods for inhibition of expression of myotilin
10/26/2012CA2833870A1 Adeno-associated virus virions with variant capsid and methods of use thereof
10/26/2012CA2831974A1 Methods for isolating and quantifying antigen from vaccines
10/25/2012US20120270808 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
10/25/2012US20120270776 Novel pesticidal toxins
10/25/2012US20120270321 Reverse genetics systems
10/25/2012US20120270292 Photo-Inactivated Viruses and Systems and Methods of Using the Same
10/25/2012US20120270238 Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269849 Attenuated influenza viruses and vaccines
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269773 Recombinant adenoviruses encoding the specific iodine transporter (nis)
10/24/2012EP2514437A1 Frozen stockpiling of influenza vaccines
10/24/2012EP2512508A1 Novel influenza virus
10/24/2012CN102747047A Human papillomaviruse type hybrid virus-like particles and preparation method thereof
10/24/2012CN102747046A Construction method and application of oncolytic adenovirus targeting CD123 positive leukemia cell
10/24/2012CN102747045A Swine influenza virus H1N1 SIVTJ inactivated vaccine and preparation method thereof
10/24/2012CN102743749A Method for preparing live attenuated rubella vaccine in human diploid cells by using basket-type bioreactor
10/24/2012CN102743748A Method for preparing swine fever live vaccine by using oscillatory type bioreactor
10/23/2012US8293515 Salmonella bacteriophage and antibacterial composition comprising the same
10/23/2012US8293498 System for generation of viable reovirus from cloned cDNA
10/23/2012CA2601006C Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
10/23/2012CA2522379C The severe acute respiratory syndrome coronavirus
10/23/2012CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/18/2012WO2012142529A2 Clonal strains of attenuated vaccinia viruses and methods of use thereof
10/18/2012WO2012099448A3 RECOMBINANT ADENOVIRUS EXPRESSING αA-CRYSTALLIN GENE AND GENE THERAPY FOR RETINAL VASCULAR DISEASE USING SAME
10/18/2012US20120266261 Neurovirulent strain of the west nile virus and uses thereof
10/18/2012US20120264616 Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 267